Several innovative treatments are revolutionizing blood sugar treatment, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide being highlighted potential options. Retatrutide, a twin GIP and GLP-1 site agonist, shows substantial weight loss along with improved glucose regulation. Cagrillintide, a GLP-1 agonist, is currently in research … Read More